ArticleBMC surgery2026
Early risk stratification of acute postoperative deep vein thrombosis with inflammatory and hemostatic molecular markers in Chinese patients undergoing unicompartmental knee arthroplasty.
Article in BMC surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundDeep vein thrombosis (DVT) is a feared postoperative complication following knee arthroplasty. However, the incidence of acute DVT, associated early risk stratification models, and optimal thromboprophylaxis after unicompartmental knee arthroplasty (UKA) remain unclear. This study aimed to comprehensively evaluate the perioperative dynamics of systemic-inflammatory and hemostatic molecular markers in patients with knee osteoarthritis undergoing UKA and to analyze their association with the occurrence of acute DVT.
methodsThe first multi-center prospective study enrolled consecutive patients undergoing unilateral UKA without routine postoperative pharmacological thromboprophylaxis from three institutions (two for derivation and one for external validation). Systemic-inflammatory and hemostatic molecular markers were measured at admission, 2-hour, 1-day, and 3-day post-UKA. Lower-extremity ultrasound was routinely conducted prior to and at 4-5 days following UKA to detect asymptomatic and symptomatic DVT. Temporal trends in these biomarkers and their relationship with acute DVT were analyzed. A nomogram was then developed to visualize individualized near-term risk stratification of acute postoperative DVT. Finally, a retrospective cohort of UKA-treated patients who received routine thromboprophylaxis was enrolled to evaluate the risk stratification performance of the identified indicators in an anticoagulated population.
resultsThe derivation cohort included 87 patients (mean age 67.8 ± 6.5 years, 78.2% female), of whom 21 (24.1%) developed acute postoperative DVT (20 asymptomatic and 1 symptomatic). Multivariate Firth's penalized logistic regression identified that higher body mass index (BMI), and elevated postoperative day 3 levels of interleukin (IL)-6, thrombin-antithrombin complex (TAT), and plasmin-α2 plasmin inhibitor complex (PIC) independently associated with an increased risk of acute DVT detected at 4-5 days post-UKA. A nomogram incorporating these four indicators demonstrated good discriminative ability, calibration, and exploratory net benefit. These findings were further validated in an independent external cohort (n = 42; mean age 67.2 ± 7.7 years; 69% female; DVT incidence, 23.8%) and in a separate cohort of 135 patients (mean age 66.4 ± 6.8 years; 77% female; DVT incidence, 20.7%) who received routine thromboprophylaxis.
conclusionA preliminary nomogram incorporating BMI and postoperative day 3 levels of IL-6, TAT, and PIC serves as a promising auxiliary tool for near-term risk stratification of acute DVT detected at 4-5 days following UKA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.